April 23, 2021
Japan’s Ministry of Health, Labor and Welfare (MHLW) approved Eli Lilly’s JAK inhibitor Olumiant (baricitinib) for the treatment of COVID-19 pneumonia on April 23, just two days after it was cleared by a key advisory panel. The drug received an...read more